date,title,source
Oct-24-18,Myovant Sciences Announces Completion of Enrollment in Phase 3 HERO Trial of Relugolix in Men with Advanced Prostate Cancer,PR Newswire
Nov-07-18,Myovant Strengthens Management Team and Adds New Directors to the Board,PR Newswire
Nov-08-18,"Myovant Provides Corporate Updates and Reports Financial Results for Second Fiscal Quarter Ended September 30, 2018",PR Newswire
